683 top medical experts on Craniopharyngioma across 36 countries and 31 U.S. states, including 612 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Neuroectodermal Tumors (593).
  4. Clinical Trials ClinicalTrials.gov : at least 49 including 3 Active, 26 Completed, 8 Recruiting
  5. Synonyms: Adamantinous Craniopharyngioma,  Papillary Craniopharyngioma,  Rathke Pouch Tumor


  

        

                    


    Computing Expert Listing ...

);